Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Portfolio Pulse from Avi Kapoor
Wall Street's most accurate analysts have provided updates on three high-yield dividend health care stocks: Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY), and Gilead Sciences, Inc. (GILD). Pfizer's dividend yield is 6.23%, with mixed analyst ratings and a recent expansion of its agreement with Saama for AI-driven data solutions. Bristol-Myers Squibb, with a 4.93% dividend yield, received a downgrade and a price target cut but reported a revenue increase in Q4. Gilead Sciences, offering a 4.19% dividend yield, also saw price target adjustments and recently announced the acquisition of CymaBay Therapeutics.
February 14, 2024 | 11:54 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bristol-Myers Squibb Company, with a 4.93% dividend yield, received a downgrade and a price target cut but reported a revenue increase in Q4.
The downgrade and price target cut could negatively impact investor sentiment, but the reported revenue increase in Q4 may offset this, leading to a neutral short-term impact on BMY's stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEUTRAL IMPACT
Pfizer Inc. has a dividend yield of 6.23% with mixed analyst ratings and a recent expansion in its AI-driven data solutions agreement with Saama.
The mixed analyst ratings and recent expansion in AI-driven data solutions suggest a neutral short-term impact on Pfizer's stock. The high dividend yield remains attractive, but analyst disagreements could create uncertainty.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Gilead Sciences, with a 4.19% dividend yield, saw price target adjustments and announced the acquisition of CymaBay Therapeutics.
The acquisition of CymaBay Therapeutics could be seen as a positive move for expanding Gilead's portfolio, potentially leading to a positive short-term impact on GILD's stock. The dividend yield remains attractive to investors.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90